About
Technology
Issues
FAQ
Links
Official Page
Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204.
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.